Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Arrowhead Pharma (NQ: ARWR)
14.52 USD  -0.11 (-0.75%)
Official Closing Price  /  Updated: 4:55 PM EST, Jan 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,529,900
Open 14.62
Bid (Size) 14.30 (2)
Ask (Size) 14.50 (3)
Prev. Close 14.63
Today's Range 14.10 - 14.96
52wk Range 5.010 - 22.39
Shares Outstanding 87,577,188
Dividend Yield N/A
Performance
YTD
+10.67%
+10.67%
1 Month
+12.82%
+12.82%
3 Month
+11.86%
+11.86%
6 Month
-12.05%
-12.05%
1 Year
+130.84%
+130.84%
Top News
More News
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia Read More
from Business Wire News Releases
Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases
Arrowhead dosed the first subjects in a Phase 1 clinical study of ARO-ANG3 for treatment of Dyslipidemias and Metabolic Diseases Read More
from Business Wire News Releases
More News
Read More
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
from Business Wire News Releases
Detailed Research: Economic Perspectives on Arrowhead Pharmaceuticals, NexGen Energy, ArcBest, Cigna, The Allstate, and Comtech Telecommunications — What Drives Growth in Today's Competitive Landscape
from GlobeNewswire News Releases
Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results
from Business Wire News Releases
Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results
from Business Wire News Releases
Here's Why Arrowhead Pharmaceuticals Shot 237.5% Higher in 2018
category Market News , NDAQ , JNJ , and 1 more.
from Motley Fool
Downtrend Call Working As Arrowhead Pharma Stock Falls 27.3% (ARWR)
from Comtex SmarTrend® News Briefs
Sum Up The Pieces: FYC Could Be Worth $55
category ETFs
from ETF Channel
Arrowhead Pharmaceuticals Presents Late-Breaking Clinical Data on ARO-AAT at Liver Meeting® 2018
from Business Wire News Releases
Why Arrowhead Pharmaceuticals Surged 11% Higher Today
category AMGN , Market News , JNJ , and 1 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X